{
    "nctId": "NCT05733026",
    "briefTitle": "Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients",
    "officialTitle": "Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Cardiotoxicity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Metastatic and localized breast cancer patients treated with Doxorubicin among chemotherapeutic protocol.\n* Measurable disease.\n* Age of 18 years to 80 years.\n* The women of childbearing age must use an effective contraception for the duration of the study.\n\nExclusion Criteria:\n\n* Breast cancer patients who had undergone radiotherapy or chemotherapy.\n* Pregnant and lactating females.\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to chemotherapeutic agents used.\n* Any other medical or psychiatric condition or severe or chronic laboratory abnormality making the inclusion of the patient in the study inappropriate in the opinion of the investigator.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}